Crossmark

The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians

Crossref DOI link: https://doi.org/10.1186/s12879-019-3862-1

Published Online: 2019-03-12

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dysoley, Lek

Kim, Saorin

Lopes, Sergio

Khim, Nimol

Bjorges, Steven

Top, Samphornarann

Huch, Chea

Rekol, Huy

Westercamp, Nelli

Fukuda, Mark M.

Hwang, Jimee

Roca-Feltrer, Arantxa

Mukaka, Mavuto

Menard, Didier

Taylor, Walter R.
License Information

Text and Data Mining valid from 2019-03-12
More Information

Article History

Received: 14 January 2019

Accepted: 1 March 2019

First Online: 12 March 2019

Ethics approval and consent to participate

: The Cambodian National Ethics Committee and the U.S. Centers for Disease Control and Prevention and was approved the study, the latter as non-engagement in human subjects research. All subjects or their legal guardians gave written informed consent to participate.

: Consent to publish was in the patient information sheet / consent from. No addition consent was required.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.